Cargando…
Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery
Autores principales: | Walsh, Mark M., Khan, Rashid, Kwaan, Hau C., Neal, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Surgeons. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015412/ https://www.ncbi.nlm.nih.gov/pubmed/33839011 http://dx.doi.org/10.1016/j.jamcollsurg.2021.03.003 |
Ejemplares similares
-
Fibrinolysis Shutdown and Thrombosis in Severe COVID-19
por: Seheult, Jansen N., et al.
Publicado: (2020) -
Hyperfibrinolysis and fibrinolysis shutdown in patients with traumatic brain injury
por: Nakae, Ryuta, et al.
Publicado: (2022) -
Standardization of Coagulation and Fibrinolysis Methods
por: Jespersen, Jörgen
Publicado: (2000) -
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
por: Wright, Franklin L., et al.
Publicado: (2020) -
Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry
por: Gomez-Builes, J. Carolina, et al.
Publicado: (2018)